Table 2.
Association of MIAT expression with clinicopathological features.
| Clinicopathological parameters studies (n) | Patients (n) | OR (95% CI) | P-value | Heterogeneity (I2, P) | Model |
|---|---|---|---|---|---|
| Age (elderly vs. non-elderly) | 1,506 | 1.07 (0.87, 1.32) | 0.516 | 0.0%, 0.995 | Fixed |
| Gender (male vs. female) | 1,418 | 0.95 (0.77, 1.19) | 0.668 | 0.0%, 0.799 | Fixed |
| Tumor size (large size vs. small size) | 814 | 2.26 (1.34, 3.81) | 0.002 | 63.8%, 0.003 | Random |
| Distant metastasis (presence vs. absence) | 1,006 | 2.54 (1.84, 3.50) | <0.001 | 19.1%, 0.289 | Fixed |
| TNM stage (III + IV vs. I + II) | 1,262 | 2.38 (1.36, 4.18) | 0.002 | 75.3%, <0.001 | Random |
| Lymph node metastasis (positive vs. negative) | 1,145 | 2.59 (1.25, 5.36) | 0.011 | 83.2%, 0.000 | Random |
| Differentiation grade (poorly and moderately vs. well) | 229 | 2.65 (1.54, 4.58) | <0.001 | 0.0%, 0.732 | Fixed |
| Histology (adenocarcinoma vs. other types) | 396 | 0.72 (0.48, 1.10) | 0.128 | 0.0%, 0.807 | Fixed |